// App-Quantinova.ai

P239 : Third generation APCA improve prediction of clinical arthritis in at-risk individuals with positive second generation ACPA

Researchers

Presenter

  • Andrea Di Matteo

Principal Investigators

  • Kulveer Mankia

  • Laurence Duquenne

  • Michael Mahler

  • Diane Corscadden

  • Katie Mbara

  • Leticia Garcia-Montoya

  • Jacqueline Nam

  • Paul Emery

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

  • Inova Diagnostics, San Diego, CA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Inflammatory Arthritis

  • Episodic ataxia 2

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved